Evidence map›Paper›PMID 35867219›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2022

Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays.

Giacomo Domenici, Gonçalo Trindade, Marta F Estrada, Ana Luísa Cartaxo, Paula M Alves, Saudade André, Catarina Brito

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.5field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Giacomo DomeniciiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Gonçalo TrindadeiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Marta F EstradaiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Ana Luísa CartaxoiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Paula M AlvesiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal.
Saudade AndréIPOLFG, Instituto Português de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
Catarina BritoiBET, Instituto de Biologia Experimental e Tecnológica, Oeiras, Portugal. anabrito@ibet.pt.
Instituto de Biologia Experimental e Tecnológica · PTUniversidade Nova de Lisboa · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is a complex and heterogeneous pathology, characterized by a variety of histological and molecular phenotypes. The majority of the breast cancers express the estrogen receptor alpha (ER), which plays a pivotal role in the pathobiology of the disease and are therefore classified as ER-positive (ER

Indexed as

NeoplasmsReceptors, EstrogenAlginatesCell Line, TumorDrug Resistance, NeoplasmSignal TransductionAlginatesReceptors, EstrogenAlginateBreast cancerEstrogen receptor signalingExplantsEx vivoPatient-derived cancer tissue cultureRT-qPCRTumor microenvironment

Identifiers

PMID35867219
OpenAlexW4286579615

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.